Your browser doesn't support javascript.
loading
Effect of once-weekly dulaglutide versus insulin glargine in people with type 2 diabetes and different baseline glycaemic patterns: A post hoc analysis of the AWARD-2 clinical trial.
Giorgino, Francesco; Yu, Maria; Haupt, Axel; Milicevic, Zvonko; García-Pérez, Luis-Emilio.
Affiliation
  • Giorgino F; Department of Emergency and Organ Transplantation, Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases, University of Bari Aldo Moro, Bari, Italy.
  • Yu M; Eli Lilly and Company, Indianapolis, Indiana.
  • Haupt A; Eli Lilly and Company, Indianapolis, Indiana.
  • Milicevic Z; Eli Lilly and Company, Indianapolis, Indiana.
  • García-Pérez LE; Eli Lilly and Company, Indianapolis, Indiana.
Diabetes Obes Metab ; 21(11): 2570-2575, 2019 11.
Article in En | MEDLINE | ID: mdl-31364266
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Fusion Proteins / Immunoglobulin Fc Fragments / Diabetes Mellitus, Type 2 / Glucagon-Like Peptides / Insulin Glargine / Hypoglycemic Agents Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Diabetes Obes Metab Journal subject: ENDOCRINOLOGIA / METABOLISMO Year: 2019 Document type: Article Affiliation country: Italy Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Fusion Proteins / Immunoglobulin Fc Fragments / Diabetes Mellitus, Type 2 / Glucagon-Like Peptides / Insulin Glargine / Hypoglycemic Agents Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Diabetes Obes Metab Journal subject: ENDOCRINOLOGIA / METABOLISMO Year: 2019 Document type: Article Affiliation country: Italy Country of publication: United kingdom